Vietnam Medtech Regulation: CSDT Applies In 2022 But IVD Industry Wary Of Pharma Influence
Executive Summary
Vietnam has adopted the ASEAN Common Submission Dossier Template and updated its medtech regulation to allow more compliance time for medtech manufacturers. But the IVD industry fears too much pharma influence in file auditing.
You may also be interested in...
Profit And Price Declaration Requirements Mar Otherwise Workable Vietnam Medtech Regulation
Vietnam’s medtech industry breathed more easily when the new decree, 98/2021, became the regulatory instrument for the sector on 1 January. While its practical approach to industry’s needs was welcomed, new price and profit declaration demands will be harder for companies to swallow.
Singapore’s Medtech Thought Leader Role And ASEAN Update
Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.
Vietnam Medtech Fast-Tracking System In Discussion, ASEAN News Catch-Up, And 2019 Asian Diaries Dates
Vietnam is the focus of this brief update to the regular Asian Medtech Associations Regulatory Networking discussions, hosted by Medtech Insight, along with the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).